202 related articles for article (PubMed ID: 31002491)
21. Identification of a 2-Aminobenzimidazole Scaffold that Potentiates Gram-Positive Selective Antibiotics Against Gram-Negative Bacteria.
Nemeth AM; Young MM; Melander RJ; Smith RD; Ernst RK; Melander C
Chembiochem; 2024 Apr; 25(8):e202400127. PubMed ID: 38451872
[TBL] [Abstract][Full Text] [Related]
22. Holarrhena antidysenterica as a resistance modifying agent against Acinetobacter baumannii: Its effects on bacterial outer membrane permeability and efflux pumps.
Chusri S; Na-Phatthalung P; Siriyong T; Paosen S; Voravuthikunchai SP
Microbiol Res; 2014; 169(5-6):417-24. PubMed ID: 24103863
[TBL] [Abstract][Full Text] [Related]
23. Synergistic efficacy of meropenem and rifampicin in a murine model of sepsis caused by multidrug-resistant Acinetobacter baumannii.
Sun Y; Wang L; Li J; Zhao C; Zhao J; Liu M; Wang S; Lu C; Shang G; Jia Y; Wen A
Eur J Pharmacol; 2014 Apr; 729():116-22. PubMed ID: 24561048
[TBL] [Abstract][Full Text] [Related]
24. Synergy and mechanism of action of α-mangostin and ceftazidime against ceftazidime-resistant Acinetobacter baumannii.
Pimchan T; Maensiri D; Eumkeb G
Lett Appl Microbiol; 2017 Oct; 65(4):285-291. PubMed ID: 28799218
[TBL] [Abstract][Full Text] [Related]
25. Bacterial Cytological Profiling as a Tool To Study Mechanisms of Action of Antibiotics That Are Active against Acinetobacter baumannii.
Htoo HH; Brumage L; Chaikeeratisak V; Tsunemoto H; Sugie J; Tribuddharat C; Pogliano J; Nonejuie P
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745382
[TBL] [Abstract][Full Text] [Related]
26. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of ARV-1502, a Proline-Rich Antimicrobial Peptide, in a Murine Model of Bacteremia Caused by Multi-Drug Resistant (MDR)
Xiong YQ; Li L; Zhou Y; Kraus CN
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382389
[No Abstract] [Full Text] [Related]
28. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
[TBL] [Abstract][Full Text] [Related]
29. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii.
Chung JH; Bhat A; Kim CJ; Yong D; Ryu CM
Sci Rep; 2016 Jun; 6():28168. PubMed ID: 27306928
[TBL] [Abstract][Full Text] [Related]
31. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
Lee S; Razqan GS; Kwon DH
Phytomedicine; 2017 Jan; 24():49-55. PubMed ID: 28160861
[TBL] [Abstract][Full Text] [Related]
33. Humanized Exposures of a β-Lactam-β-Lactamase Inhibitor, Tazobactam, versus Non-β-Lactam-β-Lactamase Inhibitor, Avibactam, with or without Colistin, against Acinetobacter baumannii in Murine Thigh and Lung Infection Models.
Monogue ML; Sakoulas G; Nizet V; Nicolau DP
Pharmacology; 2018; 101(5-6):255-261. PubMed ID: 29533955
[TBL] [Abstract][Full Text] [Related]
34. Anti-multidrug-resistant Acinetobacter baumannii activity of DS-8587: In vitro activity and in vivo efficacy in a murine calf muscle infection model.
Higuchi S; Kurosaka Y; Uoyama S; Yoshida K; Chiba M; Ishii C; Fujikawa K; Karibe Y; Hoshino K
J Infect Chemother; 2014 May; 20(5):312-6. PubMed ID: 24594453
[TBL] [Abstract][Full Text] [Related]
35. [Various antibiotic combinations against carbapenem resistant Acinetobacter baumannii infections and in vitro synergy test results (2002-2016)].
Zarakolu P; Ayaz ÇM; Metan G
Mikrobiyol Bul; 2018 Apr; 52(2):190-197. PubMed ID: 29933736
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
Alharbe R; Almansour A; Kwon DH
Int J Med Microbiol; 2017 Oct; 307(7):409-414. PubMed ID: 28781060
[TBL] [Abstract][Full Text] [Related]
37. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics.
Peleg AY; Jara S; Monga D; Eliopoulos GM; Moellering RC; Mylonakis E
Antimicrob Agents Chemother; 2009 Jun; 53(6):2605-9. PubMed ID: 19332683
[TBL] [Abstract][Full Text] [Related]
38. Emergence of antimicrobial resistance among Acinetobacter species: a global threat.
Clark NM; Zhanel GG; Lynch JP
Curr Opin Crit Care; 2016 Oct; 22(5):491-9. PubMed ID: 27552304
[TBL] [Abstract][Full Text] [Related]
39. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
[TBL] [Abstract][Full Text] [Related]
40. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
